Prasugrel - Investigational Antiplatelet Agent

 
Key Data:
Drug (brand/generic)
Prasugrel
Company/licensee
Daiichi Sankyo /Lilly
Therapy class
Thienopyridine prodrug
Product description
Antiplatelet agent
Current indication
ACS
Market sector
Cardiovascular
Development status
Phase III



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development